What are the post‑exposure prophylaxis guidelines for a health‑care worker after a needle‑stick injury from a hepatitis B surface antigen‑positive source?

Post-Exposure Prophylaxis for Hepatitis B After Needlestick Injury from HBsAg-Positive Source

For a healthcare worker with a needlestick injury from an HBsAg-positive patient, immediately administer HBIG 0.06 mL/kg intramuscularly and the first dose of hepatitis B vaccine at a separate anatomic site, preferably within 24 hours of exposure, unless the worker has documented protective immunity (anti-HBs ≥10 mIU/mL). 1

Immediate Actions (Within 24 Hours)

• Wash the needlestick site promptly with soap and water. 1
• Document the injury details (type, depth, presence of blood) and identify the source patient. 1
• Confirm the source patient's HBsAg-positive status by laboratory testing immediately. 1, 2
• Draw baseline blood from the exposed healthcare worker for anti-HBs testing before any intervention to determine immune status. 3

Management Algorithm Based on Vaccination/Immunity Status

If Documented Immunity (anti-HBs ≥10 mIU/mL)

• No treatment required—no HBIG, no vaccine booster, no testing. 1
• Documented immunity provides complete protection regardless of time since vaccination. 1

If Unvaccinated or Incompletely Vaccinated

• Give HBIG 0.06 mL/kg IM immediately (ideally within 24 hours; remains effective up to 7 days). 1, 4
• Simultaneously administer the first hepatitis B vaccine dose (20 μg for adults, 10 μg for children <10 years) at a separate anatomic site (e.g., opposite deltoid). 1, 4
• Complete the three-dose vaccine series at 0,1, and 6 months. 1, 2
• Perform anti-HBs testing 4–6 months after HBIG administration (not at 1–2 months) to avoid detecting passively transferred antibodies from HBIG. 1, 2

If Previously Vaccinated but Immunity Status Unknown

• Treat as uncertain status: immediately give HBIG 0.06 mL/kg IM plus one hepatitis B vaccine booster dose at a separate site, without waiting for serologic results. 1, 3
• The baseline blood drawn can be tested later, but do not delay prophylaxis—giving HBIG to someone already immune causes no harm, while withholding it from a non-immune person risks infection. 1
• Test anti-HBs at 4–6 months post-exposure to assess true immune status. 3
• If anti-HBs remains <10 mIU/mL after the booster, complete a second full 3-dose vaccine series and retest 1–2 months after the final dose. 3

If Documented Non-Responder (anti-HBs <10 mIU/mL after two complete 3-dose series)

• Give HBIG 0.06 mL/kg IM immediately and a second HBIG dose one month later (total of two doses). 1
• Do not give additional vaccine doses—the maximum recommended is six total doses. 1
• Test for HBsAg and anti-HBc to exclude chronic HBV infection. 3
• Counsel the healthcare worker that they remain susceptible and will require HBIG for any future HBsAg-positive exposures. 1

Critical Dosing and Administration Details

• HBIG dose: 0.06 mL/kg body weight, administered intramuscularly (typically deltoid). 1, 4
• Administer HBIG and hepatitis B vaccine at separate anatomic sites (e.g., opposite arms) to ensure optimal immune response. 1, 4
• Maximum single HBIG volume is 5 mL for very large adults despite weight-based calculations. 1

Timing and Efficacy Considerations

• HBIG effectiveness declines markedly after 7 days for percutaneous exposures; however, it remains protective up to 7 days and should not be withheld if 48–72 hours have passed. 1, 4
• The 24-hour recommendation is for optimal efficacy, not an absolute cutoff—do not withhold HBIG solely because more than 24 hours have elapsed. 1
• Combined HBIG and vaccine prophylaxis is highly effective: in one study, only 4% of vaccinated healthcare workers contracted HBV versus 33% who received HBIG alone (p<0.02). 5

Follow-Up Testing Protocol

• If HBIG was administered: Test anti-HBs at 4–6 months post-exposure to avoid false-positive results from passive antibodies. 1, 2, 3
• If HBIG was not administered: Test anti-HBs at 1–2 months after completing the vaccine series. 1
• Protective immunity is defined as anti-HBs ≥10 mIU/mL. 1

Common Pitfalls to Avoid

• Do not delay prophylaxis beyond 24 hours—effectiveness decreases significantly with delay. 2, 6, 7
• Do not withhold HBIG while awaiting serologic results when vaccination status is uncertain—immediate prophylaxis based on vaccination history is recommended. 1, 3
• Do not accept verbal history of vaccination as proof of immunity—only written, dated records of vaccination and post-vaccination serology are acceptable. 1
• Do not fail to complete the full hepatitis B vaccine series after initial post-exposure management. 2
• Do not assume HBIG is ineffective at 48–72 hours—protective activity persists through the first week. 1

Additional Considerations

• All healthcare workers with occupational HBV exposure should also be tested for HIV, syphilis, gonorrhea, and chlamydia. 2
• Healthcare facilities should maintain accurate records of exposures, post-exposure management, and follow-up testing. 2
• Healthcare personnel should have documented hepatitis B vaccination and post-vaccination serology on file before any anticipated exposure. 1